Neurologic Complications of Organ Transplantation: Multimedia

References

1. Zivkovic S. Neuroimaging and neurologic complications after organ transplantation. J Neuroimaging. Apr 2007;17(2):110-23. [Medline].

2. Patchell RA. Neurological complications of organ transplantation. Ann Neurol. Nov 1994;36(5):688-703. [Medline].

3. Conti DJ, Rubin RH. Infection of the central nervous system in organ transplant recipients. Neurol Clin. May 1988;6(2):241-60. [Medline].

4. Srinivasan A, Burton EC, Kuehnert MJ. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med. Mar 17 2005;352(11):1103-11. [Medline].

5. Schiff D, O'Neill B, Wijdicks E, Antin JH, Wen PY. Gliomas arising in organ transplant recipients: an unrecognized complication of transplantation?. Neurology. Oct 23 2001;57(8):1486-8. [Medline].

6. Wong M, Mallory GB, Goldstein J, et al. Neurologic complications of pediatric lung transplantation. Neurology. Oct 22 1999;53(7):1542-9. [Medline].

7. Neurologic complications in organ transplant recipients. In: Wijdicks EF, ed. Blue Books of Neurology. Oxford, England: Butterworth-Heinemann; 1999.

8. Bodkin CL, Eidelman BH. Sirolimus-induced posterior reversible encephalopathy. Neurology. Jun 5 2007;68(23):2039-40. [Medline].

9. Bronster DJ, Emre S, Boccagni P, et al. Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. Clin Transplant. Feb 2000;14(1):1-7. [Medline].

10. Buis CI, Wiesner RH, Krom RA, et al. Acute confusional state following liver transplantation for alcoholic liver disease. Neurology. Aug 27 2002;59(4):601-5. [Medline].

11. Campellone JV, Lacomis D, Kramer DJ, et al. Acute myopathy after liver transplantation. Neurology. Jan 1998;50(1):46-53. [Medline].

12. Chabolla DR, Wszolek ZK. Pharmacologic management of seizures in organ transplant. Neurology. Dec 26 2006;67(12 Suppl 4):S34-8. [Medline].

13. Coplin WM, Cochran MS, Levine SR, Crawford SW. Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain. May 2001;124(Pt 5):1043-51. [Medline].

14. Dyck PJ, Velosa JA, Pach JM, et al. Increased weakness after pancreas and kidney transplantation. Transplantation. Oct 27 2001;72(8):1403-8. [Medline].

15. Eidelman BH, Abu-Elmagd K, Wilson J, et al. Neurologic complications of FK 506. Transplant Proc. Dec 1991;23(6):3175-8. [Medline].

16. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. Jun 11 1998;338(24):1741-51. [Medline].

17. Guarino M, Benito-Leon J, Decruyenaere J. EFNS guidelines on management of neurological problems in liver transplantation. Eur J Neurol. Jan 2006;13(1):2-9. [Medline].

18. HHS/HRSA/HSB/DOT. 2006 OPTN/SRTR Annual Report 1996-2005. Accessed June 6, 2007. [Full Text].

19. Kleinschmidt-DeMasters BK, Marder BA, Levi ME, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol. Aug 2004;61(8):1210-20. [Medline].

20. Lewis MB, Howdle PD. Neurologic complications of liver transplantation in adults. Neurology. Nov 11 2003;61(9):1174-8. [Medline].

21. Maramattom BV, Wijdicks EF. Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients. Neurology. Nov 23 2004;63(10):1958-9. [Medline].

22. Martinez AJ. The neuropathology of organ transplantation: comparison and contrast in 500 patients. Pathol Res Pract. 1998;194(7):473-86. [Medline].

23. Mendez O, Kanal E, Abu-Elmagd KM. Granulomatous amebic encephalitis in a multivisceral transplant recipient. Eur J Neurol. Mar 2006;13(3):292-5. [Medline].

24. Mignat C. Clinically significant drug interactions with new immunosuppressiveagents. Drug Saf. Apr 1997;16(4):267-78. [Medline].

25. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf. Aug 2000;23(2):101-13. [Medline].

26. Pless M, Zivkovic SA. Neurologic complications of transplantation. Neurolog. Mar 2002;8(2):107-20. [Medline].

27. Rozen TD. Migraine Headache: Immunosuppressant Therapy. Curr Treat Options Neurol. Sep 2002;4(5):395-401. [Medline].

28. Schwartz S, Ruhnke M, Ribaud P. Improved outcome in central nervous system aspergillosis, using voriconazoletreatment. Blood. Oct 15 2005;106(8):2641-5. [Medline].

29. Sutcliffe RP, Maguire DD, Muiesan P, Dhawan A, Mieli-Vergani G, O'Grady JG. Liver transplantation for Wilson's disease: long-term results and quality-of-life assessment. Transplantation. Apr 15 2003;75(7):1003-6. [Medline].

30. Wijdicks EF. Impaired consciousness after liver transplantation. Liver Transpl Surg. Sep 1995;1(5):329-34. [Medline].

31. Wijdicks EF, Wiesner RH, Krom RA. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology. Nov 1995;45(11):1962-4. [Medline].

Further Reading

Keywords

opportunistic infection, immunosuppression, central nervous system infection, CNS infection, organ transplant, solid organ transplantation, kidney transplantation, liver transplantation, heart transplantation, lung transplantation, intestinal transplantation, posttransplant immunosuppression, opportunistic infection

Contributor Information and Disclosures

Author

Sasa Zivkovic, MD, MSc, Assistant Professor, Department of Neurology, Division of Neuromuscular Diseases, University of Pittsburgh and VA Pittsburgh Healthcare System
Sasa Zivkovic, MD, MSc is a member of the following medical societies: American Academy of Neurology and American Association of Neuromuscular and Electrodiagnostic Medicine
Disclosure: Nothing to disclose.

Medical Editor

Norman C Reynolds Jr, MD, Professor, Department of Neurology, Medical College of Wisconsin
Norman C Reynolds Jr, MD is a member of the following medical societies: American Academy of Neurology, American Chemical Society, American Clinical Neurophysiology Society, Association of Military Surgeons of the US, Movement Disorders Society, Sigma Xi, and Society for Neuroscience
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Howard S Kirshner, MD, Professor of Neurology, Psychiatry and Hearing and Speech Sciences, Vice Chairman, Department of Neurology, Vanderbilt University School of Medicine; Director, Vanderbilt Stroke Center; Program Director, Stroke Service, Vanderbilt Stallworth Rehabilitation Hospital; Consulting Staff, Department of Neurology, Nashville Veterans Affairs Medical Center
Howard S Kirshner, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Heart Association, American Medical Association, American Neurological Association, American Society of Neurorehabilitation, National Stroke Association, Phi Beta Kappa, and Tennessee Medical Association
Disclosure: Boehringer Ingelheim Honoraria Speaking and teaching; BMS/Sanofi Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching; Novartis Consulting fee Review panel membership

CME Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants
Nicholas Y Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology
Disclosure: Nothing to disclose.